Related Experiment Video
Updated: Apr 8, 2026

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
Refractory hypocalcaemia complicating metastatic prostatic carcinoma.
Christopher Rizzo1, Sandro Vella1, Mario J Cachia1
1Diabetes and Endocrine Centre, Mater Dei Hospital, Msida, Malta Department of Medicine, University of Malta Medical School, Msida, Malta.
A 72-year-old man presented with dyspnea and lethargy, found to have pneumonia, severe hypocalcemia, and vitamin D deficiency. Bone scans revealed widespread osteoblastic metastases, indicating advanced prostate cancer with metabolic complications.
Area of Science:
- Oncology
- Endocrinology
- Cardiology
Background:
- Ischaemic heart disease
- Severe hypocalcaemia
- Vitamin D deficiency
Observation:
- Right-sided lobar pneumonia
- Prolonged corrected QT interval on ECG
- Relative hypoparathyroidism
- Markedly elevated prostate-specific antigen
Findings:
- Widespread osteoblastic bone metastases on bone scintigraphy
- Persistent severe hypocalcaemia despite treatment
Implications:
- Highlights the complex interplay between advanced prostate cancer, bone metastases, and severe metabolic disturbances.
- Underscores the importance of thorough metabolic workup in patients with malignancy and cardiorespiratory symptoms.
- Suggests potential challenges in managing severe hypocalcaemia in the context of widespread bone disease.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi V: Nursing Management
Skeleton and Calcium Homeostasis
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

